Claudia Penna Selected Research

Claudia Penna Research Topics

Disease

22	Infarction (Infarctions) 01/2022 - 01/2003
19	Reperfusion Injury 09/2021 - 07/2009
19	Ischemia 12/2020 - 09/2002
7	Heart Failure 01/2022 - 01/2005
7	Myocardial Infarction 12/2020 - 03/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 01/2016
6	Hypoxia (Hypoxemia) 01/2022 - 01/2013
5	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021 - 01/2016
3	Inflammation (Inflammations) 01/2020 - 01/2018
3	Hypertension (High Blood Pressure) 01/2018 - 01/2005
3	Cardiomegaly (Heart Hypertrophy) 11/2017 - 05/2005
2	Acute Coronary Syndrome 09/2021 - 01/2021
2	Cardiotoxicity 01/2020 - 11/2019
2	Necrosis 07/2006 - 01/2003
2	Hyperemia 11/2004 - 09/2002
1	Hypercholesterolemia 03/2022
1	Muscular Diseases (Myopathy) 03/2022
1	Diabetic Cardiomyopathies 04/2020
1	ST Elevation Myocardial Infarction 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Pulmonary Hypertension 01/2018
1	Pre-Eclampsia (Preeclampsia) 01/2018
1	Disease Progression 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Heart Diseases (Heart Disease) 12/2017
1	Hypertrophy 11/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Coronary Disease (Coronary Heart Disease) 01/2017

Drug/Important Bio-Agent (IBA)

12	Phosphotransferases (Kinase)IBA 01/2020 - 07/2006
5	InflammasomesIBA 01/2020 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 07/2009
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2016 - 01/2003
4	EnzymesIBA 09/2015 - 09/2005
3	Oxygen (Dioxygen)IBA 12/2021 - 02/2018
3	salicylhydroxamic acid (SHAM)IBA 09/2021 - 07/2009
3	mitochondrial K(ATP) channelIBA 01/2018 - 07/2013
3	Adenosine Triphosphate (ATP)IBA 12/2017 - 09/2002
3	Peptides (Polypeptides)IBA 12/2017 - 05/2005
3	AntioxidantsIBA 09/2015 - 08/2011
3	chromogranin A (344-364)IBA 01/2014 - 11/2010
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2022 - 07/2013
2	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2017
2	Platelet Activating FactorIBA 01/2019 - 04/2011
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 03/2017 - 01/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 09/2005
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2015 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 01/2013
2	KATP ChannelsIBA 07/2013 - 07/2012
2	5-hydroxydecanoic acidIBA 07/2013 - 09/2002
2	Nitroblue TetrazoliumIBA 07/2012 - 11/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011 - 03/2006
2	Mitochondrial Permeability Transition PoreIBA 03/2011 - 03/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2010 - 01/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2010 - 01/2005
1	CholesterolIBA 03/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022
1	Cardioplegic SolutionsIBA 01/2022
1	laminaribioseIBA 04/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Biological ProductsIBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	LipidsIBA 12/2020
1	TicagrelorIBA 01/2020
1	Estrogens (Estrogen)FDA Link 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2019
1	AnthracyclinesIBA 11/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	CytokinesIBA 01/2019
1	CyclodextrinsIBA 02/2018
1	PolymersIBA 02/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2018
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2018
1	Advanced Glycation End ProductsIBA 01/2018
1	SaltsIBA 01/2018
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2017
1	GhrelinIBA 12/2017
1	Endothelin-1 (Endothelin 1)IBA 12/2017
1	PotassiumIBA 12/2017
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 11/2017
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2017
1	N-Me-Tyr1,D-Ala2,Asn8,Arg29-NHCH3-JI-38IBA 11/2017
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 06/2017
1	oxyhyponitriteIBA 06/2017
1	calcitonin gene-related peptide (8-37)IBA 06/2017
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 06/2017
1	ErbB Receptors (EGF Receptor)IBA 04/2017
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2016
1	NucleotidesIBA 01/2016
1	SugarsIBA 01/2016

Therapy/Procedure

7	Therapeutics 03/2022 - 06/2011
2	Percutaneous Coronary Intervention 09/2021 - 01/2021
1	Heart Transplantation (Grafting, Heart) 01/2022
1	Drug Therapy (Chemotherapy) 01/2020